Zobrazeno 1 - 10
of 65
pro vyhledávání: '"David Leather"'
Autor:
Sally Worsley, Neil Snowise, David M.G. Halpin, Dawn Midwinter, Afisi S. Ismaila, Elaine Irving, Leah Sansbury, Maggie Tabberer, David Leather, Chris Compton
Publikováno v:
ERJ Open Research, Vol 5, Iss 4 (2019)
Effectiveness studies complement conventional randomised controlled trials by providing a holistic view of treatments in the setting of usual clinical practice. We present the protocol for the ongoing INTREPID (INvestigation of TRelegy Effectiveness:
Externí odkaz:
https://doaj.org/article/2991a2b300fb4a648e86aa3265cce6df
Autor:
Ashley Woodcock, Christer Janson, Jamie Rees, Lucy Frith, Magnus Löfdahl, Alison Moore, Martin Hedberg, David Leather
Publikováno v:
Thorax. 77:1187-1192
ObjectiveTo compare the effects of switching from a pressurised metered dose inhaler (pMDI)-based to a dry powder inhaler (DPI)-based maintenance therapy versus continued usual care on greenhouse gas emissions (carbon dioxide equivalents, CO2e) and a
Autor:
Wilhelmine Meeraus, Mark Fry, Sheila McCorkindale, Jamila Astrom, Alan Barth, David Leather, Rupert Jones, Richard Yeatman, Jeanne M. Pimenta
Publikováno v:
Advances in Therapy
Introduction The Salford Lung Studies (SLS) were real-world randomised controlled trials set within UK primary care that assessed the effectiveness and safety of initiating once-daily fluticasone furoate/vilanterol versus continuing usual care in pat
Autor:
David Leatherbarrow
Publikováno v:
RA. Revista de Arquitectura, Vol 26 (2024)
Ground in this study is described as a basic premise for the emergence and retreat of images, in architecture, sculpture, painting, and landscape. Examples from different places and periods are examined, the latter ranging from the recent past, to th
Externí odkaz:
https://doaj.org/article/026e9659f57a45d3ba81f1972bb34122
Publikováno v:
The International Journal of Pharmacy Practice
Objective Creating an environment that supports conditions of routine clinical practice and enables an effectiveness trial design with a pre-licensed medicine is extremely challenging. Here, we summarise our experiences and achievements with engaging
Publikováno v:
Advances in Therapy
Traditional efficacy double-blind randomised controlled trials (DBRCTs) measure the benefit a treatment produces under near-ideal test conditions in highly selected patient populations; however, the behaviour of patients and investigators in such tri
Autor:
Ashley Woodcock, Christer Janson, Magnus Lofdahl, Lucy Frith, Jamie Rees, David Leather, Martin Hedberg, Alison Moore
Publikováno v:
Airway pharmacology and treatment.
Autor:
Kourtney J. Davis, Alexander Pate, David J. Webb, Jeanne M. Pimenta, Pinal Patel, Susan Collier, Matthew Sperrin, David Leather
Publikováno v:
Sperrin, M, Patel, P, Davis, K J, Collier, S, Pate, A, Leather, D A & Pimenta, J M 2019, ' Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data ', Pharmacoepidemiology and Drug Safety . https://doi.org/10.1002/pds.4883
Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety
PURPOSE: To validate an algorithm for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) episodes derived in an electronic health record (EHR) database, against AECOPD episodes collected in a randomized clinical trial using an elec
Autor:
Lynda C. Doward, David Leather, Diane Whalley, Henrik Svedsater, Rebecca Crawford, Nick Bosanquet, James Lay-Flurrie
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 29, Iss 1, Pp 1-9 (2019)
NPJ Primary Care Respiratory Medicine
NPJ Primary Care Respiratory Medicine
The Salford Lung Study in Asthma (SLS Asthma) was a multicentre, randomised, controlled, open-label trial that assessed initiating once-daily, single-inhaler fluticasone furoate/vilanterol (FF/VI) 100 μg/25 μg or 200 μg/25 μg versus continuing us
Follow-up interviews from The Salford Lung Study (COPD) and analyses per treatment and exacerbations
Autor:
Diane Whalley, Nick Bosanquet, James Lay-Flurrie, David Leather, Rebecca Crawford, Lynda C. Doward, Henrik Svedsater
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 29, Iss 1, Pp 1-9 (2019)
NPJ Primary Care Respiratory Medicine
NPJ Primary Care Respiratory Medicine
The Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) was a 12-month, Phase III, open-label, randomised study comparing the effectiveness and safety of initiating once-daily fluticasone furoate 100 µg/vilanterol 25 µg (FF/VI) w